1758 J . Org. Chem., Vol. 63, No. 6, 1998
Bera et al.
128.2, 127.6, 101.8, 87.7, 85.0, 81.5, 78.2, 62.1, 61.6, 47.7, 34.8.
HRMS (EI, M+) for C30H30N2O6S calcd 546.1825, obsd 546.1778.
1-[5-O-Tr it yl-3-d eoxy-3-S-(2-h yd r oxyet h ylsu lfon yl)-â-
D-a r a -fu r a n osyl]u r a cil 5. To a solution of 3 (1.63 g, 3 mmol)
in MeOH (30 mL) was added MMPP (4.5 g, 9 mmol) and the
reaction mixture was stirred at room temperature for 4-5 h.
The white residue was filtered and washed with MeOH. The
filtrate was evaporated to dryness under reduced pressure. The
residue was triturated with saturated NaHCO3 solution and
filtered. The residue was washed with NaHCO3 solution
followed by water and dried. The solid mass was then
dissolved in EtOAc, dried over Na2SO4, and filtered. The
filtrate was evaporated to dryness and the white residue was
purified over silica gel to give 5 (1.49 g, 86%). Mp: 154-155
°C. 1H NMR (CDCl3 + DMSO-d6): δ 7.58 (d, 8.1 Hz, 1H),
7.27-7.03 (m, 15H), 5.91 (d, 5.4 Hz, 1H), 5.74 (d, 1H), 5.03 (d,
8.1 Hz, 1H), 4.63 (m, 2H), 4.30 (m, 1H), 4.06 (m, 1H), 3.84 (m,
2H), 3.45-2.94 (m, 4H). 13C NMR (CDCl3 + DMSO-d6): δ
162.5, 149.4, 142.3, 140.7, 127.4, 126.7, 126.0, 99.3, 85.7, 84.1,
73.2, 70.1, 66.8, 62.8, 54.2, 54.1. HRMS (EI, M+) for
1-[5-O-Tr it yl-2,3-d id eoxy-2-N-a llyl-4H-2,3,5,6-t et r a h y-
d r o-1,4-th ia zin e-1,1-d ioxid es-â-D-r ibo-fu r a n osyl]u r a cil 10
(0.22 g, 73%). Mp: 135-137 °C. 1H-1H COSY NMR
(CDCl3): δ 7.94 (d, 8.2 Hz, 1H) H-6; 7.43-7.27 (m, 15H) trityl;
6.27 (d, 4.8 Hz, 1H) H-1′; 5.76 (m, 1H) dCH; 5.21 (m, 3H)
dCH2, H-5; 4.76 (m, 1H) H-4′; 3.85-3.49 (m, 6H) H-2′, H-3′,
H-5′, H-5′′, SO2CH2; 3.13 (m, 4H) CH2NCH2. 13C NMR
(CDCl3): δ 163.7, 150.5, 142.9, 139.9, 134.2, 128.8, 128.3, 127.7,
118.8, 102.6, 88.3, 83.9, 76.1, 68.2, 63.6, 58.8, 57.3, 47.9, 47.3.
HRMS (EI, M+) for C33H33N3O6S calcd. 599.2090, obsd 599.2081.
Gen er a l P r oced u r e for th e Syn th esis of 11-13.
A
solution of 6 (0.73 mmol) in 80% aqueous HOAc (50 mL) was
heated at 75 °C for 45 min. HOAc was removed under reduced
pressure and the residual HOAc was coevaporated with EtOH.
The solid residue was triturated with ether. The detritylated
product 7 was dissolved in MeOH (15 mL). Appropriate amine
(0.73 mmol) was added to the mixture. The suspension was
stirred at room temperature for 22-72 h. MeOH was removed
under reduced pressure. The residue was dissolved in anhy-
drous pyridine (15 mL) and benzoyl chloride (0.75 g, 5 mmol)
was added dropwise at 0 °C. The reaction mixture was stirred
at 0 °C. After 2 h the mixture was poured into saturated
NaHCO3 solution (60 mL) and extracted with chloroform (3 ×
20 mL). The chloroform part was evaporated to dryness and
the residual pyridine was coevaporated with toluene. The
product was purified over silica gel.22
C
30H30N2O8S calcd 578.1723, obsd 578.1672.
1-[5-O-Tr ityl-2,3-d id eoxy-3-S-(vin ylsu lfon yl)-â-D-glyc-
er op en t-2-en ofu r a n osyl]u r a cil 6. Compound 5 (1.15 g, 2
mmol) was dissolved in pyridine (20 mL), and mesyl chloride
(1.4 g, 12 mmol) in pyridine (5 mL) was added dropwise at 0
°C. After the addition, the reaction mixture was left at 4 °C
overnight. It was then poured into saturated NaHCO3 solution
(50 mL) and extracted with dichloromethane (3 × 20 mL). The
dichloromethane part was evaporated to dryness under re-
duced pressure and the residue was coevaporated with toluene.
The brown residue was partitioned between EtOAc (80 mL)
and water (70 mL). The EtOAc part was dried over anhydrous
Na2SO4 and filtered. The filtrate was evaporated to dryness
under reduced pressure. The residue was dissolved in anhy-
drous pyridine (30 mL) and heated at 40 °C for 1.5 h. The
solution was poured into saturated NaHCO3 solution (100 mL)
and extracted with dichloromethane (3 × 25 mL). The
dichloromethane part was evaporated and the residual pyri-
dine was coevaporated with toluene under reduced pressure.
The residue was purified over silica gel to give 6 (0.93 g, 86%).
Mp:195-198 °C. 1H-1H COSY NMR (CDCl3): δ 9.10 (bs, 1H)
NH; 7.90 (d, 8.0 Hz, 1H) H-6; 7.68-7.24 (m, 15H) trityl; 7.15
(m, 1H) H-1′; 6.80 (bs, 1H) H-2′; 6.52-6.23 (m, 2H) dCH2; 5.78
(d, 9.2 Hz, 1H) SO2CH; 5.16 (m, 1H) H-4′; 4.65 (d, 8.1 Hz, 1H)
H-5; 3.83 (m, 1H), 3.66 (m, 1H) H-5′, H-5′′. 13C NMR (CDCl3
+ DMSO-d6): δ 163.4, 150.8, 146.1, 142.9, 141.2, 138.5, 136.8,
131.4, 129.1, 128.1, 127.6, 102.3, 88.1, 87.7, 83.7, 63.3. HRMS
(EI, M+) for C30H26N2O6S calcd 542.1512, obsd 542.1467.
1-[5-O-Ben zoyl-2,3-d id eoxy-2-N-(2-O-ben zoyleth yl)-4H-
2,3,5,6-tetr a h yd r o-1,4-th ia zin e-1,1-d ioxid es-â-D-r ibo-fu r a -
n osyl]u r a cil 11 (0.235 g, 56%). Mp: 109-111 °C. 1H NMR
(CDCl3): δ 8.05 (m, 4H) and 7.68-7.35 (m, 7H), 6.13 (d, 3.1
Hz, 1H), 5.40 (dd, 8.2 Hz, 1H), 4.85-4.53 (m, 4H), 4.29 (m,
1H), 3.84 (m, 1H), 3.63 (m, 3H), 3.20 (m, 3H), 2.80 (m, 1H).
13C NMR (CDCl3): δ 166.5, 165.8, 163.5, 150.5, 139.0, 133.8,
133.3, 129.7, 129.6, 129.4, 129.1, 128.7, 128.5, 102.7, 86.1, 75.6,
68.4, 64.0, 61.8, 58.6, 52.5, 48.2. HRMS (CI, M + H+): for
C
27H28N3O9S calcd 570.1546, obsd 570.1577.
1-[5-O-Ben zoyl-2,3-d id eoxy-2-N-cycloh exyl-4H-2,3,5,6-
t et r a h yd r o-1,4-t h ia zin e-1,1-d ioxid es-â-D-r ibo-fu r a n osy-
l]u r a cil 12 (0.16 g, 58%). Mp: 125-127 °C. 1H NMR
(CDCl3): δ 8.86 (bs, 1H), 8.05-7.47 (m, 6H), 6.37 (d, 7.5 Hz,
1H), 5.60 (d, 8.1 Hz, 1H), 5.11 (m, 1H), 4.77 (m, 2H), 3.79 (m,
2H), 3.47 (m, 2H), 3.03 (m, 2H), 2.63 (m, 1H), 1.64 (m, 4H),
1.05 (m, 6H). 13C NMR (CDCl3): δ 165.9, 163.5, 150.5, 138.9,
133.9, 129.5, 129.1, 128.8, 102.9, 82.5, 73.0, 65.8, 64.2, 62.4,
58.9, 48.3, 44.7, 32.8, 31.4, 25.6, 25.4. HRMS (CI, M + H+):
for C24H30N3O7S calcd 504.1804, obsd 504.1796.
1-[5-O-Ben zoyl-2,3-d id eoxy-3-S-(2-N-b en zoyl-p -m et h -
oxya n ilin oet h ylsu lfon yl)-â-D-glycer op en t -2-en ofu r a n o-
syl]u r a cil 13 (0.19 g, 63%). Mp: 112-114 °C; 1H NMR
(CDCl3): δ 9.20 (bs, 1H), 7.99 (m, 2H), 7.60-6.70 (m, 15H),
5.57 (m, 1H), 5.18 (d, 8.1 Hz, 1H), 4.95 (2d, 1H), 4.65 (2d, 1H),
4.28 (m, 2H), 3.75 (s, 3H), 3.63 (m, 2H). 13C NMR (CDCl3): δ
171.0, 165.9, 163.3, 158.6, 150.6, 144.9, 139.9, 139.1, 135.0,
134.8, 133.6, 130.2, 129.5, 128.8, 127.9, 114.8, 103.2, 88.2, 82.7,
63.9, 55.4, 51.6, 44.7. HRMS (EI, M+): for C32H29N3O9S calcd
631.1625, obsd 631.1600.
1-[5-O-Tr ityl-3-d eoxy-3-S-(2-O-ter t-bu tyld im eth ylsilyl-
eth yl)-â-D-a r a -fu r a n osyl]u r a cil 19. To a solution of 3 (1 g,
1.8 mmol) and imidazole (0.27 g, 4 mmol) in DMF (10 mL)
was added tert-butyldimethylsilyl chloride (2.5 mmol) and the
reaction mixture was stirred at room temperature for 8 h. The
solution was then poured into ice-cold water and filtered. The
residue was dissolved in EtOAc, dried over Na2SO4, and
filtered. The filtrate was evaporated to dryness and the white
residue was purified over silica gel to give 19 (1.1 g, 93%).
Mp: 77-79 °C. 1H NMR (CDCl3): δ 9.50 (bs, 1H), 8.11 (d,
8.2 Hz, 1H), 7.46-7.27 (m, 15H), 6.16 (d, 5.2 Hz, 1H), 5.34 (d,
8.1 Hz, 1H), 4.72 (d, 1H), 4.55 (m, 1H), 3.83 (m, 3H), 3.50 (m,
3H), 2.79 (m, 2H), 0.88 (s, 9H), 0.06 (s, 6H). 13C NMR (CDCl3)
Gen er a l P r oced u r e for th e Syn th esis of 8-10.
A
mixture of 6 (0.271 g, 0.5 mmol) and the corresponding amine
(0.5 mmol) in MeOH (20 mL) was stirred at room temperature
for 22-72 h. MeOH was removed under reduced pressure.
The residue was purified over silica gel (8) or basic alumina
(9 and 10).
1-[5-O-Tr it yl-2,3-d id eoxy-2-N-isob u t yl-4H -2,3,5,6-t et -
r a h yd r o-1,4-t h ia zin e-1,1-d ioxid es-â-D-r ibo-fu r a n osyl]-
1
u r a cil 8 (0.25 g, 83%). Mp: 134-138 °C; H NMR (CDCl3):
δ 7.86 (d, 8.2 Hz, 1H), 7.37-7.27 (m, 15H), 6.31 (d, 6.1 Hz,
1H), 5.22 (d, 8.1 Hz, 1H), 4.80 (m, 1H), 3.81 (t, 1H), 3.64 (m,
4H), 3.10 (m, 3H), 2.73 (m, 1H), 2.28 (m, 1H), 1.65 (m, 1H),
0.87 (d, 6H). 13C NMR (CDCl3): δ 163.6, 150.6, 142.9, 139.6,
128.7, 128.3, 127.8, 102.6, 88.4, 83.3, 75.4, 69.2, 64.3, 62.5, 58.5,
47.7, 47.2, 27.3, 20.3, 20.2. HRMS (CI, M + H+) for
C
34H38N3O6S calcd 616.2481, obsd 616.2432.
1-[5-O-Tr ityl-2,3-dideoxy-2-N-ben zyl-4H-2,3,5,6-tetr ah y-
d r o-1,4-th ia zin e-1,1-d ioxid es-â-D-r ibo-fu r a n osyl]u r a cil 9
(0.27 g, 83%). Mp: 143-144 °C. 1H-1H COSY NMR
(CDCl3): δ 7.81 (d, 8.2 Hz, 1H) H-6; 7.43-7.22 (m, 20H)
aromatic, 6.31 (d, 4.5 Hz, 1H) H-1′; 5.13 (d, 8.2 Hz, 1H) H-5;
4.82 (m, 1H) H-4′; 4.30 (d, 14.4 Hz, 1H) one of benzyl CH2;
3.79-3.52 (m, 6H) H-3′, H-5′, H-5′′, SO2CH2 and one of benzyl
CH2; 3.20-3.09 (m, 3H) H-2′, NCH2. 13C NMR (CDCl3): δ
163.7, 150.6, 142.9, 139.5, 137.6, 128.9, 128.8, 128.3, 128.2,
127.9, 127.7, 102.6, 88.3, 84.4, 76.4, 68.7, 63.5, 58.4, 47.7.
HRMS (EI, M+) for C37H35N3O6S calcd 649.2247, obsd 649.2189.
(22) Compound 11 was synthesized in 0.73 mmol scale. Compounds
12 and 13 were prepared in 0.55 mmol scale. In the preparation of 13,
the suspension of 7 and p-methoxyaniline in MeOH was stirred at room
temperature followed by heating under reflux for 10 h to initiate
cyclization.